Evidence map›Paper›PMID 32821181›Full record

ArticleOpen access rheumatology : research and reviews2020

Rheumatoid Arthritis Saudi Database (RASD): Disease Characteristics and Remission Rates in a Tertiary Care Center.

Hani Almoallim, Rola Hassan, Mohamed Cheikh, Hanan Faruqui, Reem Alquraa, Ayman Eissa, Aous Alhazmi, Roaa Alsolaimani, Nahed Janoudi

Open access · goldAbstract read
In one paragraph

Article in Open access rheumatology : research and reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. La Tunisie medicale · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hani AlmoallimDepartment of Medicine, Faculty of Medicine, Umm Alqura University, Makkah, Saudi Arabia.ORCID 0000-0003-2582-8317
Rola HassanInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Mohamed CheikhInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.ORCID 0000-0002-1040-0126
Hanan FaruquiInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Reem AlquraaInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Ayman EissaInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Aous AlhazmiAlzaidi Chair of Research in Rheumatic Diseases, Umm Alqura University, Makkah, Saudi Arabia.
Roaa AlsolaimaniInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Nahed JanoudiInternal Medicine Department, Doctor Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.
Soliman Fakeeh Hospital · SAUmm al-Qura University · SAKing Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNational Registries are essential to direct current practice. Rheumatoid arthritis (RA) registries in the middle east and North Africa remain scarcely represented.

objectiveTo describe a population of Saudi RA patients and to compare the findings to internationally reported data.

methodsThis is an observational study that was conducted at Doctor Soliman Fakeeh Hospital (DSFH) in Saudi Arabia. The study ran from 2014 to 2018 using a pool of 433 patients. Inclusion criteria included adults older than 18 years of age who fulfilled the 2010 American College of Rheumatology criteria for the diagnosis of RA and who were also regular visitors in our rheumatology clinics. Data were collected directly from patients and entered in a specially designed program.

resultsAt initial presentation, 45.5% had demonstrated active disease (moderate or high disease activity) based on DAS-28-CRP scores, while 54.5% were in low disease activity or remission. The remission rates after 1 year had increased to 79.6% (345 patients), while 9.7% (42 patients) and 10.6% (46 patients) had low disease activity and moderate disease activity, respectively. It was also found that the female gender, higher Health Assessment Questionnaire-Disability Index (HAQ-DI) and longer lag1/lag2 periods were associated with higher disease activity in our population.

conclusionWe detected higher remission rates at 1 year of follow-up. This could be attributed to many factors, including good referral systems with easier access to biologics. We aim to expand this registry to the national level.

Indexed as

biologicsdisease-modifying antirheumatic drugsregistryremission ratesrheumatoid arthritisTNF blockers

Identifiers

PMID32821181
PMCPMC7418157
OpenAlexW3047142044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.